This course aims to further extend the student's practice of clinical pharmacy and to integrate the skills and knowledge developed in PHRM7031 and PHRM7010, The student will demonstrate their ability to take responsibility for ensuring optimal prevention of VTE and drug management in people at the extremes of age (paediatrics and geriatrics), and people suffering with cancer, terminal illness (palliative care), kidney disease, liver disease or diseases of the gastrointestinal tract.
PHRM7033 will be delivered entirely online with no face to face attendance required.
An introductory online tutorial will be held on Thursday of WEEK 1 from 7-8pm Queensland time. Students will be required to complete three (3) online Modules over the semester, which will include attendance and presentation at three online Tutorials (one per module) over the semester. The tutorials will be 2 hours in duration and held on a Thursday evening between the times of 7pm and 9pm Queensland time.
A student coming into this course will have a Bachelor of Pharmacy or equivalent. Students will be expected to have a general knowledge of skills required to practice clinical pharmacy, and should haveﾠpracticed as a pharmacist.
You'll need to complete the following courses before enrolling in this one:
PHRM7010, PHRM7031
You can't enrol in this course if you've already completed the following:
PHRM7060, PHRM7030
I am available for consultation on Thursday and Fridays (I work at the Princess Alexandra Hospital Monday to Wednesday). Please email me to make an appointment.
This course aims to develop students' knowledge, skills, capabilities, attitudes and overall competence in order to develop pharmacists into impactful, clinically informed practitioners who are professionally and socially accountable.
After successfully completing this course you should be able to:
LO1.
Access, interpret, critically appraise, and communicate current best evidence to apply to the treatment of patients with pain, cancer, terminal illness, chronic kidney disease, liver and gastrointestinal diseases.
LO2.
Access, interpret, critically appraise, and communicate current best evidence in the treatment of geriatric patients and paediatric patients.
LO3.
Access, interpret, critically appraise, and communicate current best evidence to prevent and treat venous thromboembolism (VTE).
LO4.
Apply pharmacological knowledge, evidence-based practice, clinical reasoning and ethical principles to individualise pharmaceutical care for patients with multiple complex medical conditions in situations where evidence is limited or conflicting.
LO5.
Use a systematic and respectful approach to collect clinical information, identify and prioritise problems, develop and defend solutions to identified problems for complex patients.
LO6.
Communicate with patients, peers and interdisciplinary health professionals across a range of communication technologies and formats to improve medication management.
LO7.
Learn from and with your peers to share ideas, provide and receive honest constructive feedback, and demonstrate team management skills to complete joint projects.
LO8.
Critically and insightfully reflect on your skills, knowledge and attributes relevant to clinical pharmacy and plan strategies for improvement.
| Category | Assessment task | Weight | Due date |
|---|---|---|---|
| Participation/ Student contribution |
Module Assessments
|
20% see breakdown below |
Module 1 Activities 21/08/2024 1:00 pm Module 2 Activities 18/09/2024 1:00 pm Module 3 Activities 23/10/2024 1:00 pm |
| Paper/ Report/ Annotation |
Clinical Cases
|
20% |
14/10/2024 1:00 pm |
| Examination, Presentation |
Oral VIVA
|
60% |
End of Semester Exam Period 2/11/2024 - 16/11/2024 |
A hurdle is an assessment requirement that must be satisfied in order to receive a specific grade for the course. Check the assessment details for more information about hurdle requirements.
Module 1 Activities 21/08/2024 1:00 pm
Module 2 Activities 18/09/2024 1:00 pm
Module 3 Activities 23/10/2024 1:00 pm
Module activities- 6% module 1, 6% module 2, 8% module 3 (see blackboard for details)
There are three modules that comprise this assessment item: Module 1 (6%), Module 2 (6%), Module 3 (8%).
The mark for each module is derived from a series of blogs, quizzes, and a group oral presentation.
The Tutorials will be run at 7pm on the Thursday after (next day) the module activities are due.
(i) Blogs
Students are required to post blog entries. Postings must demonstrate that the task has been well thought through and completed. Postings must be reflective, insightful and succinct. Be mindful that students are required to read many contributions. Meaningfully comment on the posting of at least one student. Comments such as "I agree with you that Amlodipine is a good choice for hypertension in this patient" or "Why did you choose amlodipine" or " well done, interesting case" are okay to post but will not gain marks. In order to obtain marks you need to post meaningful comments e.g. "I agree with you that Amlodipine is a good choice for hypertension in this patient, as the ACC/AHA guidelines recommend avoiding ACE Inhibitors in patients with this ethnicity" or "Why did you choose amlodipine?" Even though this patient's ethnicity means they do not respond to an ACE Inhibitor, a betablocker may provide mortality benefit with his heart failure". Contributions should provide a perspective that contributes to the learning of others.
(ii) Surveys / Quizzes / Tests
Provide answers to a series of questions. The correctness of answers will not be considered in the allocation of marks. However in order to obtain marks it must be clear that students have made a meaningful attempt at the questions with follow up to correct the questions answered incorrectly. A reasonable attempt is defined as achieving at least 70% of all answers correct on final attempt.
(iii) Blue discussion boards and Tutorial presentation
Students are required to contribute to the (Blue) Tutorial Discussion Boards for each module to prepare for the Tutorial. Each student will be assigned a group by the course coordinator.
Groups will prepare the presentation for the online tutorial. The group presentation will be marked by the course coordinator. Marking criteria for this assessment is available in Blackboard. A 16:9 PowerPoint format should be used. The recommended template is available to download in Blackboard. The online tutorials are scheduled for two hours on Thursday evenings from 7-9 pm Queensland time (check daylight saving for Southern states). These will be the day after the module activities are due. Each group member will be required to the post individual contributions on the blue discussion board and one member from each group will be required to upload their PowerPoint slides for the tutorial onto the blue discussion board for their group by the due date for module activities.
These assessment tasks evaluate students' abilities, skills and knowledge without the aid of generative Artificial Intelligence (AI). Students are advised that the use of AI technologies to develop responses is strictly prohibited and may constitute student misconduct under the Student Code of Conduct.
Submission: All tasks must be submitted electronically via Learn.UQ by the due date/time. Resubmission will not be allowed
You cannot defer or apply for an extension for this assessment.
Late submissions will not be allocated grades
14/10/2024 1:00 pm
Students are to develop recommendations for 3 clinical cases in their allocated groups. One group member in each group will upload the group's recommendations for the clinical cases. Each group will be allocated a group mark that will be adjusted for each student based on their documented contribution. Students will be encouraged to work through these cases using the Green Discussion Boards. Evidence of individual student contribution is required in order to obtain marks, and evidence of student contribution will be determined by posting of meaningful contributions within their group's Green Discussion Board and commenting on other students posts.
See blackboard for assessment criteria.
Submission: A Word file must be submitted electronically via Learn.UQ by the due date/time.
You cannot defer or apply for an extension for this assessment.
A penalty of 10% of the maximum possible mark will be deducted per 24 hours from time submission is due for up to 7 days. After 7 days, you will receive a mark of 0.
End of Semester Exam Period
2/11/2024 - 16/11/2024
The online oral VIVA will be scheduled for a specific time via Zoom. The schedule will be announced during the semester. Each student will be presented with a case. You will have 20 minutes to prepare the case, identifying any potential or actual medication related problems and your recommendations. You will then present and defend your findings using evidence to an examiner for 20 minutes, who will ask you questions relating to the case and your responses. This is an open book examination.
The viva provides an opportunity to demonstrate the knowledge and skills developed throughout the program of study. Cases will incorporate a range of clinical topics including those discussed in PHRM7031 and PHRM7010 (prerequisites for the course).
This viva will be recorded and retained as per university policy. The recording will be stored in a secure manner and will only be accessed if required for the purposes of moderation of marking; provision of feedback to the student; and/or re-marking following a successful re-mark application.
This task has been designed to be challenging, authentic and complex. Whilst students may use Artificial Intelligence (AI) technologies, successful completion of assessment in this course will require students to critically engage in specific contexts and tasks for which artificial intelligence will provide only limited support and guidance. To pass this assessment, students will be required to demonstrate detailed comprehension of the VIVA independent of AI tools.
| Planning time | 20 minutes |
|---|---|
| Duration | 20 minutes |
| Calculator options | Any calculator permitted |
| Open/closed book | Open Book examination |
| Materials | All written or electronic materials permitted |
| Exam platform | Other |
| Invigilation | Not invigilated |
Submission: The VIVA will be completed as an online with one student and one assessor.
Resubmission: Students who receive a failing grade (i.e. obtain less than 50% of available marks) will be offered one opportunity to resit; the maximum grade that can be achieved for this assessment on a resit will be a pass (50% of available marks). Students who are granted a resit for an assessment item and do not attend on the scheduled date will not be granted a deferred resit exam.
You may be able to defer this exam.
Full criteria for each grade is available in the Assessment Procedure.
| Grade | Cut off Percent | Description |
|---|---|---|
| 1 (Low Fail) | 1 - 29 |
Absence of evidence of achievement of course learning outcomes. |
| 2 (Fail) | 30 - 44 |
Minimal evidence of achievement of course learning outcomes. |
| 3 (Marginal Fail) | 45 - 49 |
Demonstrated evidence of developing achievement of course learning outcomes |
| 4 (Pass) | 50 - 64 |
Demonstrated evidence of functional achievement of course learning outcomes. |
| 5 (Credit) | 65 - 74 |
Demonstrated evidence of proficient achievement of course learning outcomes. |
| 6 (Distinction) | 75 - 84 |
Demonstrated evidence of advanced achievement of course learning outcomes. |
| 7 (High Distinction) | 85 - 100 |
Demonstrated evidence of exceptional achievement of course learning outcomes. |
Supplementary assessment is available for this course.
In order to pass this course students must obtain at least 50% overall for the course AND 50% or greater for the oral VIVA assessment component.
You'll need the following resources to successfully complete the course. We've indicated below if you need a personal copy of the reading materials or your own item.
Find the required and recommended resources for this course on the UQ Library website.
Reading will be made available within each module. Access to the internet and UQ email is essential.
Zoom: Access to Zoom via your UQ student account will be required for certain synchronous online classes each week (workshops).
The learning activities for this course are outlined below. Learn more about the learning outcomes that apply to this course.
Filter activity type by
| Learning period | Activity type | Topic |
|---|---|---|
Multiple weeks From Week 1 To Week 6 |
Problem-based learning |
Module 1: Cancer, VTE, pain and palliative care Introduction to cancer, venous thromboembolism (VTE), palliative care, acute and chronic pain Learning outcomes: L01, L03, L04, L05, L06, L07, L08 |
Multiple weeks From Week 5 To Mid Sem break |
Problem-based learning |
Module 2: Gastrointestinal, Kidney and Liver Gastrointestinal disorders, evaluation and treatment of liver disease, acute and chronic kidney disease Learning outcomes: L01, L04, L05, L06, L07, L08 |
Week 5 |
Tutorial |
Module 1 Tutorial The tutorial will be on THURSDAY NIGHT between 7-9pm Learning outcomes: L01, L03, L04, L05, L06, L07, L08 |
Multiple weeks From Week 9 To Week 13 |
Problem-based learning |
Module 3: Paediatrics and Geriatrics Treatment of common disorders in children, and in the elderly including polypharmacy and deprescribing Learning outcomes: L02, L04, L05, L06, L07, L08 |
Week 9 |
Tutorial |
Module 2 Tutorial The tutorial will be on THURSDAY NIGHT between 7-9pm Learning outcomes: L01, L04, L05, L06, L07, L08 |
Week 13 |
Tutorial |
Module 3 Tutorial The tutorial will be on THURSDAY NIGHT between 7-9pm Learning outcomes: L02, L04, L05, L06, L07, L08 |
University policies and procedures apply to all aspects of student life. As a UQ student, you must comply with University-wide and program-specific requirements, including the:
Learn more about UQ policies on my.UQ and the Policy and Procedure Library.